In This Issue: Mini-Theme on Geriatric Care and Cancer Screening

Document Type


Publication Date



This issue includes several articles pertinent to geriatric medicine,1–6 along with a related commentary by Warshaw.7 In a striking pair of articles, Hudson4 provides evidence suggesting that prostate-specific antigen (PSA) testing is dramatically overused, whereas Mohan6 reports that men overestimate the value of treating prostate cancer diagnosed by PSA screening; both of these conditions lead to overtreatment. Although the US Preventive Services Task Force (USPSTF)8 does not recommend regular prostate cancer screening with PSA testing at any age group, even those professional groups that do recommend testing do not suggest doing so in men of advanced age. However, physicians and their patients are not following any of these guidelines when it comes to PSA testing, as reported by Hudson et al.4